These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 9813634)

  • 1. Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals.
    de Water R; Boevé ER; van Miert PP; Deng G; Cao LC; Stijnen T; de Bruijn WC; Schröder FH
    Scanning Microsc; 1996; 10(2):591-601; discussion 601-3. PubMed ID: 9813634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
    Li Y; McMartin KE
    Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological and immunocytochemical changes in chronic calcium oxalate nephrolithiasis in the rat.
    de Water R; Boevé ER; van Miert PP; Vermaire CP; van Run PR; Cao LC; de Bruijn WC; Schröder FH
    Scanning Microsc; 1996; 10(2):577-87; discussion 587-90. PubMed ID: 9813633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation?
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; Schröder FH
    Scanning Microsc; 1995 Mar; 9(1):103-14. PubMed ID: 8553009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology of calcium oxalate nephrolithiasis in rats. II. The role of the papilla in stone formation.
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; van 't Noordende JM; Schrder FH
    Scanning Microsc; 1995 Mar; 9(1):115-24; discussion 124-5. PubMed ID: 8553010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of macrophages in nephrolithiasis in rats: an analysis of the renal interstitium.
    de Water R; Noordermeer C; Houtsmuller AB; Nigg AL; Stijnen T; Schröder FH; Kok DJ
    Am J Kidney Dis; 2000 Sep; 36(3):615-25. PubMed ID: 10977795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity.
    Corley RA; Wilson DM; Hard GC; Stebbins KE; Bartels MJ; Soelberg JJ; Dryzga MD; Gingell R; McMartin KE; Snellings WM
    Toxicol Appl Pharmacol; 2008 Apr; 228(2):165-78. PubMed ID: 18191429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies.
    Thamilselvan S; Khan SR
    J Nephrol; 1998; 11 Suppl 1():66-9. PubMed ID: 9604816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study on several models of experimental renal calcium oxalate stones formation in rats.
    Liu J; Cao Z; Zhang Z; Zhou S; Ye Z
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):83-7. PubMed ID: 17393118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-vitamin E diet exacerbates calcium oxalate crystal formation via enhanced oxidative stress in rat hyperoxaluric kidney.
    Huang HS; Ma MC; Chen J
    Am J Physiol Renal Physiol; 2009 Jan; 296(1):F34-45. PubMed ID: 18799548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin inhibits renal crystal retention in a rat stone forming model.
    Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
    J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals.
    Huang HS; Ma MC; Chen J; Chen CF
    Neurourol Urodyn; 2003; 22(2):176-82. PubMed ID: 12579636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.
    Thamilselvan S; Hackett RL; Khan SR
    J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
    Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
    Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.